US Patent Issued to Purdue Pharma on Aug. 5 for "Compounds for treating lymphoma or a T-cell malignant disease" (Swiss, Spanish Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,076, issued on Aug. 5, was assigned to Purdue Pharma LP (Stamford, Conn.).

"Compounds for treating lymphoma or a T-cell malignant disease" was invented by Katarina Hilgier (Zurich), Francisco Ibanez Lopez (Alicante, Spain) and Thomas Jorg Mehrling (Riehen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to tinostamustine for use in the treatment of lymphoma or a T-cell malignant disease. Tinostamustine may cause side effects when administered to a patient, and it is desirable to minimise such effects. The present invention defines an improved treatment, wherein the dose of tinostamustine administered is varied based o...